These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3210536)

  • 1. Effect of fasting on lysosomes in kidney cortex of glomerulonephritic rats.
    Haga HJ; Andersen KJ; Iversen BM; Ofstad J; Dobrota M; Matre R
    Kidney Int; 1988 Dec; 34(6):766-73. PubMed ID: 3210536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in lysosome populations in the rat kidney cortex induced by passive Heymann glomerulonephritis.
    Haga HJ; Andersen KJ; Iversen BM; Ofstad J; Dobrota M; Matre R
    Ren Physiol; 1987; 10(5):249-60. PubMed ID: 3136521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lysosome populations in the rat kidney cortex induced by experimental proteinuria.
    Haga HJ; Andersen KJ; Rygh T; Iversen BM; Matre R
    Int J Biochem; 1988; 20(8):793-800. PubMed ID: 3049182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomes of the renal cortex: heterogeneity and role in protein handling.
    Andersen KJ; Haga HJ; Dobrota M
    Kidney Int; 1987 Apr; 31(4):886-97. PubMed ID: 3586495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin reduces proteinuria in passive Heymann nephritis in rats.
    Zoja C; Benigni A; Verroust P; Ronco P; Bertani T; Remuzzi G
    Kidney Int; 1987 Jun; 31(6):1335-43. PubMed ID: 2956450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of fibronectin-related substances in normal and passive Heymann nephritis rats.
    Nishizawa Y; Fukai F; Natori Y; Katayama T
    Biol Pharm Bull; 1998 May; 21(5):429-33. PubMed ID: 9635494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis.
    Katoh T; Lianos EA; Fukunaga M; Takahashi K; Badr KF
    J Clin Invest; 1993 Apr; 91(4):1507-15. PubMed ID: 8386188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of albuminuria by a calcium antagonist, manidipine, in rats with passive Heymann nephritis.
    Arai T; Kobayashi S; Nakajima T; Hishida A
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1216-20. PubMed ID: 7853752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
    Wang Y; Tong J; Tang R; Dong H; Xu J
    Nephron Physiol; 2004; 98(3):p80-8. PubMed ID: 15528953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
    Neale TJ; Ojha PP; Exner M; Poczewski H; Rüger B; Witztum JL; Davis P; Kerjaschki D
    J Clin Invest; 1994 Oct; 94(4):1577-84. PubMed ID: 7929834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
    Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
    Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary modulations of protein intake on the progression of glomerulosclerosis in unilaterally nephrectomized rats with passive Heymann nephritis.
    Kawaguchi H; Yamaguchi Y; Hattori M; Nagata M; Nagata M; Kohno M; Itoh K
    Nephron; 1988; 50(3):233-46. PubMed ID: 3265761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of VEGF and its receptors in two rat models of proteinuria.
    Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
    Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.
    Blume C; Heise G; Hess A; Waldner C; Grabensee B; Schroer K; Heering P
    Nephron Exp Nephrol; 2005; 100(2):e104-12. PubMed ID: 15855806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy.
    Stahl RA; Adler S; Baker PJ; Chen YP; Pritzl PM; Couser WG
    Kidney Int; 1987 May; 31(5):1126-31. PubMed ID: 3474470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.